NCT06390059Phase 2Completed

EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma

Study sponsor: NovoCure Ltd. · NVCR

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-11-18Actual
Enrollment · participants84Actual
Source updated2026-09-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 27 Nov 2025. After: 18 Nov 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview